Publicaciones en colaboración con investigadores/as de National Institutes of Health (20)

2023

  1. Survival after Invasive or Conservative Management of Stable Coronary Disease

    Circulation, Vol. 147, Núm. 1, pp. 8-19

2022

  1. ENETS standardized (synoptic) reporting for endoscopy in neuroendocrine tumors

    Journal of Neuroendocrinology, Vol. 34, Núm. 3

2021

  1. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

    Nature Communications, Vol. 12, Núm. 1

  2. Erratum: Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature communications (2021) 12 1 (1078))

    Nature communications

  3. One-year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab

    European Journal of Haematology, Vol. 106, Núm. 3, pp. 389-397

  4. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

    npj Breast Cancer, Vol. 7, Núm. 1

2019

  1. Minimal clinically important improvement of routine assessment of patient index data 3 in rheumatoid arthritis

    Journal of Rheumatology, Vol. 46, Núm. 1, pp. 27-30

2016

  1. International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment

    Journal of Clinical Oncology, Vol. 34, Núm. 13, pp. 1544-1557

2015

  1. Candidate genetic modifiers for breast and ovarian cancer risk inBRCA1andBRCA2 mutation carriers

    Cancer Epidemiology Biomarkers and Prevention, Vol. 24, Núm. 1, pp. 308-316

2013

  1. Global Mortality Estimates for the 2009 Influenza Pandemic from the GLaMOR Project: A Modeling Study

    PLoS Medicine, Vol. 10, Núm. 11

2012

  1. Colon cancer molecular subtypes identified by expression profiling and associated to stroma, mucinous type and different clinical behavior

    BMC Cancer, Vol. 12

2009

  1. Infection prevention and control in health-care facilities in which hematopoietic cell transplant recipients are treated

    Bone Marrow Transplantation, Vol. 44, Núm. 8, pp. 495-507

  2. Safe living after hematopoietic cell transplantation

    Bone Marrow Transplantation, Vol. 44, Núm. 8, pp. 509-519

2008

  1. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

    Clinical Infectious Diseases, Vol. 46, Núm. 12, pp. 1813-1821

2007

  1. Isolated CNS Whipple disease: Acute onset and relapsing-remitting course

    Scandinavian Journal of Infectious Diseases, Vol. 39, Núm. 6-7, pp. 623-625

2004

  1. Levodopa in the treatment of Parkinson's disease: Current controversies

    Movement Disorders, Vol. 19, Núm. 9, pp. 997-1005

2001

  1. Duration of ruptured membranes and vertical transmission of HIV-1: A meta-analysis from 15 prospective cohort studies

    AIDS, Vol. 15, Núm. 3, pp. 357-368

2000

  1. In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease

    Journal of Infectious Diseases, Vol. 182, Núm. 2, pp. 526-533

1999

  1. Modality-specific frontal and parietal areas for auditory and visual spatial localization in humans

    Nature Neuroscience, Vol. 2, Núm. 8, pp. 759-766

1993

  1. Gangliosides in neurological diseases [26]

    British Medical Journal